Is Genmab A/S (GMAB) a Buy, Sell, or Hold?
Genmab A/S
NASDAQ:GMAB
$28.73 USD
-$0.07 (-0.24%)
- Volume
- 1.63M
- Average Volume
- 1.94M
- Market Capitalization
- $17.64B
- P/E Ratio
- 21.40
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $35.43
- Year Low
- $21.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.18
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
-28.2% DOWNSIDE
$40.00 Price Target
UPSIDE/DOWNSIDE HIGH
-30.8% DOWNSIDE
$41.50 Price Target High
UPSIDE/DOWNSIDE LOW
-10.2% DOWNSIDE
$32.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Truist Financial | Gregory Renza | $40 | $26.89 | 2026-05-27 06:09 AM | 48.8% |
| Guggenheim | Michael Schmidt | $40 | $29.29 | 2026-02-23 06:31 AM | 36.6% |
| Jefferies | Benjamin Jackson | $41.5 | $30.03 | 2026-02-17 04:26 AM | 38.2% |
| Truist Financial | Asthika Goonewardene | $48 | $28.84 | 2025-11-06 03:03 PM | 66.4% |
| Truist Financial | Asthika Goonewardene | $49 | $33.56 | 2025-10-06 07:12 AM | 46.0% |
| Leerink Partners | Jonathan Chang | $34 | $29.1566 | 2025-09-29 01:04 PM | 16.6% |